AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Biomarkers for Gastric and Colon Cancer

Summary

The expression or methylation of tumor suppressor genes is used as biomarkers for the diagnosis and prognosis of gastric and colon cancer, and methods for inhibiting the growth of gastric and colon cancer.

Highlights: • Tumor suppressor genes in gastric cancer (ZNF545, ADAMTS9, DACT1, RNF180, BCL6B & PAX5) Tumor suppressor gene in colon cancer (TBX5) • Transcriptional silencing is directly associated with promoter methylation • Methylation of core promoter regions was detected in gastric or colon cancer tissues, but not normal gastric or colon tissues • Methylation status of the genes is associated with tumor aggressiveness and patient survival

Application No.

480, 479, 444, 418, 362, 361, 319

Others

Inventor(s): Prof Joseph SUNG, Prof YU Jun and Dr Xiaoxing LI \ Department of Medicine and Therapeutics Licensing Status: Available

Country/Region

Hong Kong

For more information, please click Here